{
    "startDate": "2019-04-01",
    "endDate": "2019-12-31",
    "year": "2020",
    "quarter": "Q3",
    "symbol": "UROV",
    "data": {
        "bs": [
            {
                "label": "Cash and cash equivalents",
                "concept": "CashAndCashEquivalentsAtCarryingValue",
                "unit": "usd",
                "value": 131921000
            },
            {
                "label": "Restricted cash",
                "concept": "RestrictedCashCurrent",
                "unit": "usd",
                "value": 243000
            },
            {
                "label": "Prepaid expenses and other current assets",
                "concept": "PrepaidExpenseAndOtherAssetsCurrent",
                "unit": "usd",
                "value": 10182000
            },
            {
                "label": "Due from Sumitovant Pharma Ltd.",
                "concept": "DueFromRelatedPartiesCurrent",
                "unit": "usd",
                "value": 111000
            },
            {
                "label": "Current assets:",
                "concept": "AssetsCurrent",
                "unit": "usd",
                "value": 142457000
            },
            {
                "label": "Furniture and equipment, net",
                "concept": "PropertyPlantAndEquipmentNet",
                "unit": "usd",
                "value": 1241000
            },
            {
                "label": "Operating lease right-of-use assets",
                "concept": "OperatingLeaseRightOfUseAsset",
                "unit": "usd",
                "value": 3219000
            },
            {
                "label": "Restricted cash, net of current portion",
                "concept": "RestrictedCashNoncurrent",
                "unit": "usd",
                "value": 623000
            },
            {
                "label": "Other assets",
                "concept": "AssetsNoncurrentOtherThanNoncurrentInvestmentsAndPropertyPlantAndEquipment",
                "unit": "usd",
                "value": 11000
            },
            {
                "label": "Assets",
                "concept": "Assets",
                "unit": "usd",
                "value": 147551000
            },
            {
                "label": "Accounts payable",
                "concept": "AccountsPayableCurrent",
                "unit": "usd",
                "value": 2388000
            },
            {
                "label": "Accrued expenses",
                "concept": "AccruedLiabilitiesCurrent",
                "unit": "usd",
                "value": 14701000
            },
            {
                "label": "Due to Roivant Sciences Ltd.",
                "concept": "DueToRelatedPartiesCurrent",
                "unit": "usd",
                "value": 7000
            },
            {
                "label": "Interest payable",
                "concept": "InterestPayableCurrent",
                "unit": "usd",
                "value": 343000
            },
            {
                "label": "Current portion of long-term debt",
                "concept": "LongTermDebtCurrent",
                "unit": "usd",
                "value": 43760000
            },
            {
                "label": "Current portion of operating lease liabilities",
                "concept": "OperatingLeaseLiabilityCurrent",
                "unit": "usd",
                "value": 335000
            },
            {
                "label": "Total current liabilities",
                "concept": "LiabilitiesCurrent",
                "unit": "usd",
                "value": 61534000
            },
            {
                "label": "Long-term debt, net of current portion",
                "concept": "LongTermDebtNoncurrent",
                "unit": "usd",
                "value": 87287000
            },
            {
                "label": "Operating lease liabilities, net of current portion",
                "concept": "OperatingLeaseLiabilityNoncurrent",
                "unit": "usd",
                "value": 3179000
            },
            {
                "label": "Liabilities and Shareholders' (Deficit) Equity",
                "concept": "Liabilities",
                "unit": "usd",
                "value": 152000000
            },
            {
                "label": "Commitments and contingencies (Note 9)",
                "concept": "CommitmentsAndContingencies",
                "unit": "usd",
                "value": "N/A"
            },
            {
                "label": "Common shares, par value $0.000037453 per share, 267,001,308 shares authorized, 30,519,688 and 30,322,911 issued and outstanding at December 31, 2019 and March 31, 2019, respectively",
                "concept": "CommonStockValue",
                "unit": "usd",
                "value": 1000
            },
            {
                "label": "Common shares subscribed",
                "concept": "CommonStockShareSubscribedButUnissuedSubscriptionsReceivable",
                "unit": "usd",
                "value": 1000
            },
            {
                "label": "Accumulated other comprehensive income",
                "concept": "AccumulatedOtherComprehensiveIncomeLossNetOfTax",
                "unit": "usd",
                "value": 394000
            },
            {
                "label": "Additional paid-in capital",
                "concept": "AdditionalPaidInCapitalCommonStock",
                "unit": "usd",
                "value": 266173000
            },
            {
                "label": "Accumulated deficit",
                "concept": "RetainedEarningsAccumulatedDeficit",
                "unit": "usd",
                "value": -271016000
            },
            {
                "label": "Shareholders' (deficit) equity",
                "concept": "StockholdersEquity",
                "unit": "usd",
                "value": -4449000
            },
            {
                "label": "Liabilities and Shareholders' (Deficit) Equity",
                "concept": "LiabilitiesAndStockholdersEquity",
                "unit": "usd",
                "value": 147551000
            }
        ],
        "cf": [
            {
                "label": "Net loss",
                "concept": "ProfitLoss",
                "unit": "usd",
                "value": -95485000
            },
            {
                "label": "Depreciation and amortization",
                "concept": "DepreciationAndAmortization",
                "unit": "usd",
                "value": 178000
            },
            {
                "label": "Share-based compensation expense",
                "concept": "ShareBasedCompensation",
                "unit": "usd",
                "value": 14797000
            },
            {
                "label": "Amortization of debt discount and issuance costs",
                "concept": "AmortizationOfFinancingCostsAndDiscounts",
                "unit": "usd",
                "value": 664000
            },
            {
                "label": "Non-cash operating lease cost.",
                "concept": "urov:NoncashOperatingLeaseCost",
                "unit": "usd",
                "value": 448000
            },
            {
                "label": "Loss on disposal of furniture and equipment",
                "concept": "GainLossOnSaleOfPropertyPlantEquipment",
                "unit": "usd",
                "value": -236000
            },
            {
                "label": "Unrealized foreign currency translation adjustment",
                "concept": "ForeignCurrencyTransactionGainLossUnrealized",
                "unit": "usd",
                "value": -125000
            },
            {
                "label": "Prepaid expenses and other current assets",
                "concept": "IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets",
                "unit": "usd",
                "value": -2897000
            },
            {
                "label": "Other assets",
                "concept": "IncreaseDecreaseInOtherCurrentAssets",
                "unit": "usd",
                "value": -77000
            },
            {
                "label": "Due from Sumitovant Pharma Ltd.",
                "concept": "IncreaseDecreaseInDueFromRelatedPartiesCurrent",
                "unit": "usd",
                "value": 111000
            },
            {
                "label": "Increase (decrease) in due to related party current.",
                "concept": "urov:IncreaseDecreaseInDueToRelatedPartyCurrent",
                "unit": "usd",
                "value": -8000
            },
            {
                "label": "Accounts payable",
                "concept": "IncreaseDecreaseInAccountsPayable",
                "unit": "usd",
                "value": 463000
            },
            {
                "label": "Accrued expenses",
                "concept": "IncreaseDecreaseInAccruedLiabilities",
                "unit": "usd",
                "value": 4998000
            },
            {
                "label": "Increase (decrease) in operating lease liabilities.",
                "concept": "urov:IncreaseDecreaseInOperatingLeaseLiabilities",
                "unit": "usd",
                "value": -153000
            },
            {
                "label": "Interest payable",
                "concept": "IncreaseDecreaseInInterestPayableNet",
                "unit": "usd",
                "value": 343000
            },
            {
                "label": "Cash flows from operating activities:",
                "concept": "NetCashProvidedByUsedInOperatingActivities",
                "unit": "usd",
                "value": -70531000
            },
            {
                "label": "Purchases of furniture and equipment",
                "concept": "PaymentsToAcquireFurnitureAndFixtures",
                "unit": "usd",
                "value": 732000
            },
            {
                "label": "Cash flows from investing activities:",
                "concept": "NetCashProvidedByUsedInInvestingActivities",
                "unit": "usd",
                "value": -732000
            },
            {
                "label": "Proceeds from capital contributions from Roivant Sciences Ltd.",
                "concept": "ProceedsFromContributedCapital",
                "unit": "usd",
                "value": 251000
            },
            {
                "label": "Proceeds from exercise of stock options",
                "concept": "ProceedsFromStockOptionsExercised",
                "unit": "usd",
                "value": 718000
            },
            {
                "label": "Debt financing costs paid",
                "concept": "PaymentsOfDebtIssuanceCosts",
                "unit": "usd",
                "value": 387000
            },
            {
                "label": "Deferred offering costs paid",
                "concept": "PaymentsOfStockIssuanceCosts",
                "unit": "usd",
                "value": 165000
            },
            {
                "label": "Cash proceeds from debt financing",
                "concept": "ProceedsFromIssuanceOfDebt",
                "unit": "usd",
                "value": 117500000
            },
            {
                "label": "Payment of restricted stock units tax withholding on net settlement",
                "concept": "PaymentsRelatedToTaxWithholdingForShareBasedCompensation",
                "unit": "usd",
                "value": 63000
            },
            {
                "label": "Cash flows from financing activities:",
                "concept": "NetCashProvidedByUsedInFinancingActivities",
                "unit": "usd",
                "value": 117854000
            },
            {
                "label": "Net change in cash, cash equivalents and restricted cash",
                "concept": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
                "unit": "usd",
                "value": 46591000
            },
            {
                "label": "Warrants issued with long-term debt.",
                "concept": "urov:WarrantsIssuedWithLongTermDebt",
                "unit": "usd",
                "value": 438000
            },
            {
                "label": "Debt financing costs included in accrued expenses",
                "concept": "DebtIssuanceCostsIncurredDuringNoncashOrPartialNoncashTransaction",
                "unit": "usd",
                "value": 213000
            },
            {
                "label": "Income taxes",
                "concept": "IncomeTaxesPaidNet",
                "unit": "usd",
                "value": 61000
            },
            {
                "label": "Interest",
                "concept": "InterestPaidNet",
                "unit": "usd",
                "value": 1641000
            }
        ],
        "ic": [
            {
                "label": "Research and development",
                "concept": "ResearchAndDevelopmentExpense",
                "unit": "usd",
                "value": 62909000
            },
            {
                "label": "General and administrative",
                "concept": "GeneralAndAdministrativeExpense",
                "unit": "usd",
                "value": 29587000
            },
            {
                "label": "Operating expenses:",
                "concept": "OperatingExpenses",
                "unit": "usd",
                "value": 92496000
            },
            {
                "label": "Interest expense, net",
                "concept": "InterestIncomeExpenseNet",
                "unit": "usd",
                "value": -2495000
            },
            {
                "label": "Loss on disposal of furniture and equipment",
                "concept": "GainLossOnSaleOfPropertyPlantEquipment",
                "unit": "usd",
                "value": -236000
            },
            {
                "label": "Other income (expense):",
                "concept": "OtherNonoperatingIncomeExpense",
                "unit": "usd",
                "value": -145000
            },
            {
                "label": "Loss before provision for income taxes",
                "concept": "IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
                "unit": "usd",
                "value": -95372000
            },
            {
                "label": "Provision for income taxes",
                "concept": "IncomeTaxExpenseBenefit",
                "unit": "usd",
                "value": 113000
            },
            {
                "label": "Net loss",
                "concept": "NetIncomeLoss",
                "unit": "usd",
                "value": -95485000
            },
            {
                "label": "Net loss per common share\u2014basic and diluted",
                "concept": "EarningsPerShareBasicAndDiluted",
                "unit": "usd/shares",
                "value": -3.14
            },
            {
                "label": "Weighted average common shares outstanding\u2014basic and diluted",
                "concept": "WeightedAverageNumberOfShareOutstandingBasicAndDiluted",
                "unit": "shares",
                "value": 30365142
            },
            {
                "label": "Foreign currency translation adjustment",
                "concept": "OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent",
                "unit": "usd",
                "value": 125000
            },
            {
                "label": "Other comprehensive income (loss):",
                "concept": "OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent",
                "unit": "usd",
                "value": 125000
            },
            {
                "label": "Comprehensive loss",
                "concept": "ComprehensiveIncomeNetOfTax",
                "unit": "usd",
                "value": -95360000
            }
        ]
    }
}